Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: Converging evidence from human and animal research

Behavioural Brain Research

Volumn 193, Issue 1, 2008, Pages 1-16

  Portugal, George S ^a   Gould, Thomas J ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

Acetylcholine; Addiction; Genetics; Mice; Nicotine; Withdrawal

Indexed keywords

NICOTINIC RECEPTOR;

GENE CLUSTER; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEREDITY; HUMAN; KNOCKOUT MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TOBACCO DEPENDENCE;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; MICE, KNOCKOUT; NICOTINE; RECEPTORS, NICOTINIC; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 47849083570     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.05.006     Document Type: Review

References (192)

1. Amos C.I., Wu X., Broderick P., Gorlov I.P., Gu J., Eisen T., et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 40 (2008) 616-622
2. André J.M., Gulick D., Portugal G.S., and Gould T.J. Nicotine withdrawal disrupts both foreground and background contextual fear conditioning but not pre-pulse inhibition of the acoustic startle response in C57BL/6 mice. Behav Brain Res 190 (2008) 174-181
3. Baker T.B., Brandon T.H., and Chassin L. Motivational influences on cigarette smoking. Annu Rev Psychol 55 (2004) 463-491
4. Benowitz N.L. Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addition. N Engl J Med 319 (1988) 1318-1330
5. Benowitz N.L., Porchet H., and Jacob III P. Nicotine dependence and tolerance in man: pharmacokinetic and pharmacodynamic investigations. Prog Brain Res 79 (1989) 279-287
6. Berrettini W., Yuan X., Tozzi F., Song K., Francks C., Chilcoat H., et al. alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol Psychiatry 13 (2008) 368-373
7. Besson M., David V., Suarez S., Cormier A., Cazala P., Changeux J.P., et al. Genetic dissociation of two behaviors associated with nicotine addiction: beta-2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome. Psychopharmacology (Berl) 187 (2006) 189-199
8. Bierut L.J., Madden P.A., Breslau N., Johnson E.O., Hatsukami D., Pomerleau O.F., et al. Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet 16 (2007) 24-35
9. Booker T.K., Butt C.M., Wehner J.M., Heinemann S.F., and Collins A.C. Decreased anxiety-like behavior in beta3 nicotinic receptor subunit knockout mice. Pharmacol Biochem Behav 87 (2007) 146-157
10. Breslau N., Johnson E.O., Hiripi E., and Kessler R. Nicotine dependence in the United States: prevalence, trends, and smoking persistence. Arch Gen Psychiatry 58 (2001) 810-816
11. Broide R.S., Salas R., Ji D., Paylor R., Patrick J.W., Dani J.A., et al. Increased sensitivity to nicotine-induced seizures in mice expressing the L250T alpha 7 nicotinic acetylcholine receptor mutation. Mol Pharmacol 61 (2002) 695-705
12. Brower V.G., Fu Y., Matta S.G., and Sharp B.M. Rat strain differences in nicotine self-administration using an unlimited access paradigm. Brain Res 930 (2002) 12-20
13. Butt C.M., King N.M., Hutton S.R., Collins A.C., and Stitzel J.A. Modulation of nicotine but not ethanol preference by the mouse Chrna4 A529T polymorphism. Behav Neurosci 119 (2005) 26-37
14. Cahill K., Stead L.F., and Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev (2007) CD006103
15. Carter R.M., Hofstotter C., Tsuchiya N., and Koch C. Working memory and fear conditioning. Proc Natl Acad Sci USA 100 (2003) 1399-1404
16. Center for Disease Control. Cigarette smoking among adults-United States, 1995. MMWR Morb Mortal Wkly Rep 46 (1997) 1217-1220
17. Center for Disease Control. Annual smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 1997-2001. MMWR Morb Mortal Wkly Rep 54 (2005) 625-628
18. Chambers R.A., Taylor J.R., and Potenza M.N. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry 160 (2003) 1041-1052
19. Champtiaux N., Han Z.Y., Bessis A., Rossi F.M., Zoli M., Marubio L., et al. Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice. J Neurosci 22 (2002) 1208-1217
20. Champtiaux N., and Changeux J.P. Knockout and knockin mice to investigate the role of nicotinic receptors in the central nervous system. Prog Brain Res 145 (2004) 235-251
21. Coe J.W., Brooks P.R., Vetelino M.G., Wirtz M.C., Arnold E.P., Huang J., et al. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem 48 (2005) 3474-3477
22. Collins A.C., Miner L.L., and Marks M.J. Genetic influences on acute responses to nicotine and nicotine tolerance in the mouse. Pharmacol Biochem Behav 30 (1988) 269-278
23. Collins A.C., and Marks M.J. Chronic nicotine exposure and brain nicotinic receptors-influence of genetic factors. Prog Brain Res 79 (1989) 137-146
24. Committee on Standardized Genetic Nomenclature for Mice. Rules for nomenclature of inbred strains. In: Lyon M.F., and Searle A.G. (Eds). Genetic variants and strains of the laboratory mouse (1989), Oxford University Press, New York 632-635
25. Cordero-Erausquin M., Marubio L.M., Klink R., and Changeux J.P. Nicotinic receptor function: new perspectives from knockout mice. Trends Pharmacol Sci 21 (2000) 211-217
26. Cryan J.F., Bruijnzeel A.W., Skjei K.L., and Markou A. Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Psychopharmacology (Berl) 168 (2003) 347-358
27. Cui C., Booker T.K., Allen R.S., Grady S.R., Whiteaker P., Marks M.J., et al. The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors. J Neurosci 23 (2003) 11045-11053
28. Damaj M.I., Kao W., and Martin B.R. Characterization of spontaneous and precipitated nicotine withdrawal in the mouse. J Pharmacol Exp Ther 307 (2003) 526-534
29. Damaj M.I., Fonck C., Marks M.J., Deshpande P., Labarca C., Lester H.A., et al. Genetic approaches identify differential roles for alpha4beta2* nicotinic receptors in acute models of antinociception in mice. J Pharmacol Exp Ther 321 (2007) 1161-1169
30. Davis J.A., James J.R., Siegel S.J., and Gould T.J. Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice. J Neurosci 25 (2005) 8708-8713
31. Davis J.A., Porter J., and Gould T.J. Nicotine enhances both foreground and background contextual fear conditioning. Neurosci Lett 394 (2006) 202-205
32. Davis J.A., Kenney J.W., and Gould T.J. Hippocampal alpha4beta2 nicotinic acetylcholine receptor involvement in the enhancing effect of acute nicotine on contextual fear conditioning. J Neurosci 27 (2007) 10870-10877
33. Davis J.A., and Gould T.J. Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning. Neuropsychopharmacology 32 (2007) 2011-2019
34. Davis J.A., and Gould T.J. beta2 subunit-containing nicotinic receptors mediate the enhancing effect of nicotine on trace cued fear conditioning in C57BL/6 mice. Psychopharmacology (Berl) 190 (2007) 343-352
35. Davis J.A., and Gould T.J. Associative learning, the hippocampus, and nicotine addiction. Curr Drug Abuse Rev 1 (2008) 9-19
36. Dobelis P., Marks M.J., Whiteaker P., Balogh S.A., Collins A.C., and Stitzel J.A. A polymorphism in the mouse neuronal alpha4 nicotinic receptor subunit results in an alteration in receptor function. Mol Pharmacol 62 (2002) 334-342
37. Dols M., Willems B., van den Hout M., and Bittoun R. Smokers can learn to influence their urge to smoke. Addict Behav 25 (2000) 103-108
38. Dols M., van den Hout M., Kindt M., and Willems B. The urge to smoke depends on the expectation of smoking. Addiction 97 (2002) 87-93
39. Due D.L., Huettel S.A., Hall W.G., and Rubin D.C. Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. Am J Psychiatry 159 (2002) 954-960
40. Ehringer M.A., Clegg H.V., Collins A.C., Corley R.P., Crowley T., Hewitt J.K., et al. Association of the neuronal nicotinic receptor beta2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine. Am J Med Genet B Neuropsychiatr Genet 144 (2007) 596-604
41. Elders M.J., Perry C.L., Eriksen M.P., and Giovino G.A. The report of the Surgeon General: preventing tobacco use among young people. Am J Public Health 84 (1994) 543-547
42. Fagen Z.M., Mansvelder H.D., Keath J.R., and McGehee D.S. Short- and long-term modulation of synaptic inputs to brain reward areas by nicotine. Ann NY Acad Sci 1003 (2003) 185-195
43. Faraday M.M., O'Donoghue V.A., and Grunberg N.E. Effects of nicotine and stress on startle amplitude and sensory gating depend on rat strain and sex. Pharmacol Biochem Behav 62 (1999) 273-284
44. Faraday M.M., O'Donoghue V.A., and Grunberg N.E. Effects of nicotine and stress on locomotion in Sprague-Dawley and Long-Evans male and female rats. Pharmacol Biochem Behav 74 (2003) 325-333
45. Feng Y., Niu T., Xing H., Xu X., Chen C., Peng S., et al. A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men. Am J Hum Genet 75 (2004) 112-121
46. Fenster C.P., Rains M.F., Noerager B., Quick M.W., and Lester R.A. Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine. J Neurosci 17 (1997) 5747-5759
47. Flores C.M., Rogers S.W., Pabreza L.A., Wolfe B.B., and Kellar K.J. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol 41 (1992) 31-37
48. Franklin T.R., Wang Z., Wang J., Sciortino N., Harper D., Li Y., et al. Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study. Neuropsychopharmacology 32 (2007) 2301-2309
49. Geier A., Mucha R.F., and Pauli P. Appetitive nature of drug cues confirmed with physiological measures in a model using pictures of smoking. Psychopharmacology (Berl) 150 (2000) 283-291
50. Gelernter J., Panhuysen C., Weiss R., Brady K., Poling J., Krauthammer M., et al. Genomewide linkage scan for nicotine dependence: identification of a chromosome 5 risk locus. Biol Psychiatry 61 (2007) 119-126
51. Gil Z., Sack R.A., Kedmi M., Harmelin A., and Orr-Urtreger A. Increased sensitivity to nicotine-induced seizures in mice heterozygous for the L250T mutation in the alpha7 nicotinic acetylcholine receptor. Neuroreport 13 (2002) 191-196
52. Gill K.J., and Boyle A.E. Genetic basis for the psychostimulant effects of nicotine: a quantitative trait locus analysis in AcB/BcA recombinant congenic mice. Genes Brain Behav 4 (2005) 401-411
53. Gommans J., Stolerman I.P., and Shoaib M. Antagonism of the discriminative and aversive stimulus properties of nicotine in C57BL/6J mice. Neuropharmacology 39 (2000) 2840-2847
54. Gould T.J., and Wehner J.M. Nicotine enhancement of contextual fear conditioning. Behav Brain Res 102 (1999) 31-39
55. Gould T.J., and Wehner J.M. Genetic influences on latent inhibition. Behav Neurosci 113 (1999) 1291-1296
56. Gould T.J., and Higgins S.J. Nicotine enhances contextual fear conditioning in C57BL/6J mice at 1 and 7 days post-training. Neurobiol Learn Mem 80 (2003) 147-157
57. Gould T.J., Feiro O., and Moore D. Nicotine enhances trace cued fear conditioning but not delay cued fear conditioning in C57BL/6 mice. Behav Brain Res 155 (2004) 167-173
58. Gould T.J. Nicotine and hippocampus-dependent learning: implications for addiction. Mol Neurobiol 34 (2006) 93-107
59. Grabus S.D., Martin B.R., and Imad Damaj M. Nicotine physical dependence in the mouse: involvement of the alpha7 nicotinic receptor subtype. Eur J Pharmacol 515 (2005) 90-93
60. Grabus S.D., Martin B.R., Brown S.E., and Damaj M.I. Nicotine place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists. Psychopharmacology (Berl) 184 (2006) 456-463
61. Greenbaum L., Kanyas K., Karni O., Merbl Y., Olender T., Horowitz A., et al. Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes. Mol Psychiatry 11 (2006) 312-22, 223
62. Gritz E.R., Prokhorov A.V., Hudmon K.S., Chamberlain R.M., Taylor W.C., DiClemente C.C., et al. Cigarette smoking in a multiethnic population of youth: methods and baseline findings. Prev Med 27 (1998) 365-384
63. Gritz E.R., Prokhorov A.V., Hudmon K.S., Mullin Jones M., Rosenblum C., Chang C.C., et al. Predictors of susceptibility to smoking and ever smoking: a longitudinal study in a triethnic sample of adolescents. Nicotine Tob Res 5 (2003) 493-506
64. Henningfield J.E., and Keenan R.M. Nicotine delivery kinetics and abuse liability. J Consult Clin Psychol 61 (1993) 743-750
65. Hettema J.M., Corey L.A., and Kendler K.S. A multivariate genetic analysis of the use of tobacco, alcohol, and caffeine in a population based sample of male and female twins. Drug Alcohol Depend 57 (1999) 69-78
66. Hirschhorn J.N., and Daly M.J. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6 (2005) 95-108
67. Ho M.K., and Tyndale R.F. Overview of the pharmacogenomics of cigarette smoking. Pharmacogenomics J 7 (2007) 81-98
68. Hogg R.C., Raggenbass M., and Bertrand D. Nicotinic acetylcholine receptors: from structure to brain function. Rev Physiol Biochem Pharmacol 147 (2003) 1-46
69. Horan B., Smith M., Gardner E.L., Lepore M., and Ashby Jr. C.R. (-)-Nicotine produces conditioned place preference in Lewis, but not Fischer 344 rats. Synapse 26 (1997) 93-94
70. Hughes J.R., Gust S.W., Skoog K., Keenan R.M., and Fenwick J.W. Symptoms of tobacco withdrawal. A replication and extension. Arch Gen Psychiatry 48 (1991) 52-59
71. Hughes J.R., Higgins S.T., and Bickel W.K. Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities. Addiction 89 (1994) 1461-1470
72. Hughes J.R., Stead L.F., and Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev (2007) CD000031
73. Hughes J.R. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res 9 (2007) 315-327
74. Hung R.J., McKay J.D., Gaborieau V., Boffetta P., Hashibe M., Zaridze D., et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452 (2008) 633-637
75. Hutchison K.E., Allen D.L., Filbey F.M., Jepson C., Lerman C., Benowitz N.L., et al. CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. Arch Gen Psychiatry 64 (2007) 1078-1086
76. Hyman S.E., and Malenka R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2 (2001) 695-703
77. Jackson K.J., Martin B.R., Changeux J.P., and Damaj M.I. Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J Pharmacol Exp Ther 325 (2008) 302-312
78. Jacobsen L.K., Krystal J.H., Mencl W.E., Westerveld M., Frost S.J., and Pugh K.R. Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biol Psychiatry 57 (2005) 56-66
79. Jacobsen L.K., Mencl W.E., Constable R.T., Westerveld M., and Pugh K.R. Impact of smoking abstinence on working memory neurocircuitry in adolescent daily tobacco smokers. Psychopharmacology (Berl) 193 (2007) 557-566
80. Kendler K.S., Neale M.C., Sullivan P., Corey L.A., Gardner C.O., and Prescott C.A. A population-based twin study in women of smoking initiation and nicotine dependence. Psychol Med 29 (1999) 299-308
81. Kenny P.J., and Markou A. Conditioned nicotine withdrawal profoundly decreases the activity of brain reward systems. J Neurosci 25 (2005) 6208-6212
82. Klink R., de Kerchove d'Exaerde A., Zoli M., and Changeux J.P. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci 21 (2001) 1452-1463
83. Koopmans J.R., Slutske W.S., Heath A.C., Neale M.C., and Boomsma D.I. The genetics of smoking initiation and quantity smoked in Dutch adolescent and young adult twins. Behav Genet 29 (1999) 383-393
84. Kosten T.A., Miserendino M.J., Haile C.N., DeCaprio J.L., Jatlow P.I., and Nestler E.J. Acquisition and maintenance of intravenous cocaine self-administration in Lewis and Fischer inbred rat strains. Brain Res 778 (1997) 418-429
85. Kulak J.M., Nguyen T.A., Olivera B.M., and McIntosh J.M. Alpha-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes. J Neurosci 17 (1997) 5263-5270
86. Labarca C., Schwarz J., Deshpande P., Schwarz S., Nowak M.W., Fonck C., et al. Point mutant mice with hypersensitive alpha 4 nicotinic receptors show dopaminergic deficits and increased anxiety. Proc Natl Acad Sci USA 98 (2001) 2786-2791
87. Lander E., and Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11 (1995) 241-247
88. Lazev A.B., Herzog T.A., and Brandon T.H. Classical conditions of environmental cues to cigarette smoking. Exp Clin Psychopharmacol 7 (1999) 56-63
89. Le Novere N., Zoli M., and Changeux J.P. Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. Eur J Neurosci 8 (1996) 2428-2439
90. Le Novere N., Corringer P.J., and Changeux J.P. The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences. J Neurobiol 53 (2002) 447-456
91. Lessov C.N., Martin N.G., Statham D.J., Todorov A.A., Slutske W.S., Bucholz K.K., et al. Defining nicotine dependence for genetic research: evidence from Australian twins. Psychol Med 34 (2004) 865-879
92. Li M.D., Ma J.Z., Cheng R., Dupont R.T., Williams N.J., Crews K.M., et al. A genome-wide scan to identify loci for smoking rate in the Framingham Heart Study population. BMC Genet 4 Suppl. 1 (2003) S103
93. Li M.D., Cheng R., Ma J.Z., and Swan G.E. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 98 (2003) 23-31
94. Li M.D., Beuten J., Ma J.Z., Payne T.J., Lou X.Y., Garcia V., et al. Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. Hum Mol Genet 14 (2005) 1211-1219
95. Li M.D., Payne T.J., Ma J.Z., Lou X.Y., Zhang D., Dupont R.T., et al. A genomewide search finds major susceptibility loci for nicotine dependence on chromosome 10 in African Americans. Am J Hum Genet 79 (2006) 745-751
96. Li M.D., Ma J.Z., Payne T.J., Lou X.Y., Zhang D., Dupont R.T., et al. Genome-wide linkage scan for nicotine dependence in European Americans and its converging results with African Americans in the Mid-South Tobacco Family sample. Mol Psychiatry 13 (2008) 407-416
97. Li X.C., Karadsheh M.S., Jenkins P.M., Brooks J.C., Drapeau J.A., Shah M.S., et al. Chromosomal loci that influence oral nicotine consumption in C57BL/6J × C3H/HeJ F2 intercross mice. Genes Brain Behav 6 (2007) 401-410
98. Loukola A., Broms U., Maunu H., Widen E., Heikkila K., Siivola M., et al. Linkage of nicotine dependence and smoking behavior on 10q, 7q and 11p in twins with homogeneous genetic background. Pharmaconomics J 8 (2008) 209-219
99. Lueders K.K., Hu S., McHugh L., Myakishev M.V., Sirota L.A., and Hamer D.H. Genetic and functional analysis of single nucleotide polymorphisms in the beta2-neuronal nicotinic acetylcholine receptor gene (CHRNB2). Nicotine Tob Res 4 (2002) 115-125
100. Madden P.A., Heath A.C., Pedersen N.L., Kaprio J., Koskenvuo M.J., and Martin N.G. The genetics of smoking persistence in men and women: a multicultural study. Behav Genet 29 (1999) 423-431
101. Maes H.H., Woodard C.E., Murrelle L., Meyer J.M., Silberg J.L., Hewitt J.K., et al. Tobacco, alcohol and drug use in eight- to sixteen-year-old twins: the Virginia Twin Study of Adolescent Behavioral Development. J Stud Alcohol 60 (1999) 293-305
102. Malin D.H., Lake J.R., Newlin-Maultsby P., Roberts L.K., Lanier J.G., Carter V.A., et al. Rodent model of nicotine abstinence syndrome. Pharmacol Biochem Behav 43 (1992) 779-784
103. Malin D.H. Nicotine dependence: studies with a laboratory model. Pharmacol Biochem Behav 70 (2001) 551-559
104. Marks M.J., Stitzel J.A., and Collins A.C. Genetic influences on nicotine responses. Pharmacol Biochem Behav 33 (1989) 667-678
105. Marks M.J., Romm E., Campbell S.M., and Collins A.C. Variation of nicotinic binding sites among inbred strains. Pharmacol Biochem Behav 33 (1989) 679-689
106. Marks M.J., Campbell S.M., Romm E., and Collins A.C. Genotype influences the development of tolerance to nicotine in the mouse. J Pharmacol Exp Ther 259 (1991) 392-402
107. Martin S., Manzanares J., Corchero J., Garcia-Lecumberri C., Crespo J.A., Fuentes J.A., et al. Differential basal proenkephalin gene expression in dorsal striatum and nucleus accumbens, and vulnerability to morphine self-administration in Fischer 344 and Lewis rats. Brain Res 821 (1999) 350-355
108. Marubio L.M., del Mar Arroyo-Jimenez M., Cordero-Erausquin M., Lena C., Le Novere N., de Kerchove d'Exaerde A., et al. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 398 (1999) 805-810
109. Marubio L.M., Gardier A.M., Durier S., David D., Klink R., Arroyo-Jimenez M.M., et al. Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors. Eur J Neurosci 17 (2003) 1329-1337
110. Maskos U., Molles B.E., Pons S., Besson M., Guiard B.P., Guilloux J.P., et al. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436 (2005) 103-107
111. Matta S.G., Balfour D.J., Benowitz N.L., Boyd R.T., Buccafusco J.J., Caggiula A.R., et al. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) 190 (2007) 269-319
112. Mayhew K.P., Flay B.R., and Mott J.A. Stages in the development of adolescent smoking. Drug Alcohol Depend 59 Suppl. 1 (2000) S61-81
113. McCallum S.E., Collins A.C., Paylor R., and Marks M.J. Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation. Psychopharmacology (Berl) 184 (2006) 314-327
114. McEchron M.D., Bouwmeester H., Tseng W., Weiss C., and Disterhoft J.F. Hippocampectomy disrupts auditory trace fear conditioning and contextual fear conditioning in the rat. Hippocampus 8 (1998) 638-646
115. McGue M., Elkins I., and Iacono W.G. Genetic and environmental influences on adolescent substance use and abuse. Am J Med Genet 96 (2000) 671-677
116. McIlvain H., Susman J.L., Davis C., and Gilbert C. Physician counseling for smoking cessation: is the glass half empty?. J Fam Pract 40 (1995) 148-152
117. Mendrek A., Monterosso J., Simon S.L., Jarvik M., Brody A., Olmstead R., et al. Working memory in cigarette smokers: comparison to non-smokers and effects of abstinence. Addict Behav 31 (2006) 833-844
118. Mihalak K.B., Carroll F.I., and Luetje C.W. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol 70 (2006) 801-805
119. Millar N.S. Assembly and subunit diversity of nicotinic acetylcholine receptors. Biochem Soc Trans 31 (2003) 869-874
120. Morley K.I., Medland S.E., Ferreira M.A., Lynskey M.T., Montgomery G.W., Heath A.C., et al. A possible smoking susceptibility locus on chromosome 11p12: evidence from sex-limitation linkage analyses in a sample of Australian twin families. Behav Genet 36 (2006) 87-99
121. Muller U. Ten years of gene targeting: targeted mouse mutants, from vector design to phenotype analysis. Mech Dev 82 (1999) 3-21
122. Naylor C., Quarta D., Fernandes C., and Stolerman I.P. Tolerance to nicotine in mice lacking alpha7 nicotinic receptors. Psychopharmacology (Berl) 180 (2005) 558-563
123. Orr-Urtreger A., Goldner F.M., Saeki M., Lorenzo I., Goldberg L., De Biasi M., et al. Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J Neurosci 17 (1997) 9165-9171
124. Orr-Urtreger A., Broide R.S., Kasten M.R., Dang H., Dani J.A., Beaudet A.L., et al. Mice homozygous for the L250T mutation in the alpha7 nicotinic acetylcholine receptor show increased neuronal apoptosis and die within 1 day of birth. J Neurochem 74 (2000) 2154-2166
125. Papke R.L., Sanberg P.R., and Shytle R.D. Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes. J Pharmacol Exp Ther 297 (2001) 646-656
126. Parish C.L., Nunan J., Finkelstein D.I., McNamara F.N., Wong J.Y., Waddington J.L., et al. Mice lacking the alpha4 nicotinic receptor subunit fail to modulate dopaminergic neuronal arbors and possess impaired dopamine transporter function. Mol Pharmacol 68 (2005) 1376-1386
127. Pergadia M.L., Heath A.C., Martin N.G., and Madden P.A. Genetic analyses of DSM-IV nicotine withdrawal in adult twins. Psychol Med 36 (2006) 963-972
128. Philibin S.D., Vann R.E., Varvel S.A., Covington III H.E., Rosecrans J.A., James J.R., et al. Differential behavioral responses to nicotine in Lewis and Fischer-344 rats. Pharmacol Biochem Behav 80 (2005) 87-92
129. Picciotto M.R., Zoli M., Lena C., Bessis A., Lallemand Y., Le Novere N., et al. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 374 (1995) 65-67
130. Picciotto M.R., Zoli M., Rimondini R., Lena C., Marubio L.M., Pich E.M., et al. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391 (1998) 173-177
131. Picciotto M.R., and Corrigall W.A. Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics. J Neurosci 22 (2002) 3338-3341
132. Portugal G.S., and Gould T.J. Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning. Pharmacol Biochem Behav 88 (2007) 179-187
133. Portugal G.S., Kenney J.W., and Gould T.J. beta2 subunit containing acetylcholine receptors mediate nicotine withdrawal deficits in the acquisition of contextual fear conditioning. Neurobiol Learn Mem 89 (2008) 106-113
134. Quinn J.J., Loya F., Ma Q.D., and Fanselow M.S. Dorsal hippocampus NMDA receptors differentially mediate trace and contextual fear conditioning. Hippocampus 15 (2005) 665-674
135. Raybuck JD, Portugal GS, Lerman C, Gould TJ. Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice. Behav Neurosci; in press.
136. Rehm J., Taylor B., and Room R. Global burden of disease from alcohol, illicit drugs and tobacco. Drug Alcohol Rev 25 (2006) 503-513
137. Rice D.P. Economic costs of substance abuse, 1995. Proc Assoc Am Physicians 111 (1999) 119-125
138. Risch N., and Merikangas K. The future of genetic studies of complex human diseases. Science 273 (1996) 1516-1517
139. Risinger F.O., and Oakes R.A. Nicotine-induced conditioned place preference and conditioned place aversion in mice. Pharmacol Biochem Behav 51 (1995) 457-461
140. Robinson S.F., Marks M.J., and Collins A.C. Inbred mouse strains vary in oral self-selection of nicotine. Psychopharmacology (Berl) 124 (1996) 332-339
141. Rukstalis M., Jepson C., Patterson F., and Lerman C. Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy. J Subst Abuse Treat 28 (2005) 297-304
142. Saccone S.F., Hinrichs A.L., Saccone N.L., Chase G.A., Konvicka K., Madden P.A., et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 16 (2007) 36-49
143. Sack R., Gochberg-Sarver A., Rozovsky U., Kedmi M., Rosner S., and Orr-Urtreger A. Lower core body temperature and attenuated nicotine-induced hypothermic response in mice lacking the beta4 neuronal nicotinic acetylcholine receptor subunit. Brain Res Bull 66 (2005) 30-36
144. Salas R., Orr-Urtreger A., Broide R.S., Beaudet A., Paylor R., and De Biasi M. The nicotinic acetylcholine receptor subunit alpha 5 mediates short-term effects of nicotine in vivo. Mol Pharmacol 63 (2003) 1059-1066
145. Salas R., Pieri F., Fung B., Dani J.A., and De Biasi M. Altered anxiety-related responses in mutant mice lacking the beta4 subunit of the nicotinic receptor. J Neurosci 23 (2003) 6255-6263
146. Salas R., Pieri F., and De Biasi M. Decreased signs of nicotine withdrawal in mice null for the beta4 nicotinic acetylcholine receptor subunit. J Neurosci 24 (2004) 10035-10039
147. Salas R., Cook K.D., Bassetto L., and De Biasi M. The alpha3 and beta4 nicotinic acetylcholine receptor subunits are necessary for nicotine-induced seizures and hypolocomotion in mice. Neuropharmacology 47 (2004) 401-407
148. Salas R., Main A., Gangitano D., and De Biasi M. Decreased withdrawal symptoms but normal tolerance to nicotine in mice null for the alpha7 nicotinic acetylcholine receptor subunit. Neuropharmacology 53 (2007) 863-869
149. Salminen O., Murphy K.L., McIntosh J.M., Drago J., Marks M.J., Collins A.C., et al. Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol Pharmacol 65 (2004) 1526-1535
150. Schlaepfer I.R., Hoft N.R., Collins A.C., Corley R.P., Hewitt J.K., Hopfer C.J., et al. The CHRNA5/A3/B4 gene cluster variability as an important determinant of early alcohol and tobacco initiation in young adults. Biol Psychiatry 63 (2008) 1039-1046
151. Shoaib M., Schindler C.W., and Goldberg S.R. Nicotine self-administration in rats: strain and nicotine pre-exposure effects on acquisition. Psychopharmacology (Berl) 129 (1997) 35-43
152. Shoaib M., Gommans J., Morley A., Stolerman I.P., Grailhe R., and Changeux J.P. The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion. Neuropharmacology 42 (2002) 530-539
153. Silagy C., Lancaster T., Stead L., Mant D., and Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev (2004) CD000146
154. Silverman M.A., Neale M.C., Sullivan P.F., Harris-Kerr C., Wormley B., Sadek H., et al. Haplotypes of four novel single nucleotide polymorphisms in the nicotinic acetylcholine receptor beta2-subunit (CHRNB2) gene show no association with smoking initiation or nicotine dependence. Am J Med Genet 96 (2000) 646-653
155. Singer G., Simpson F., and Lang W.J. Schedule induced self injections of nicotine with recovered body weight. Pharmacol Biochem Behav 9 (1978) 387-389
156. Skjei K.L., and Markou A. Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats. Psychopharmacology (Berl) 168 (2003) 280-292
157. Stamm E.R., and Schlesinger K. Effects of cycloheximide administered in conjunction with nicotine on retention of a passive avoidance task in mice. J Comp Physiol Psychol 94 (1980) 1184-1190
158. Stevens J.C., Banks G.T., Festing M.F., and Fisher E.M. Quiet mutations in inbred strains of mice. Trends Mol Med 13 (2007) 512-519
159. Stitzel J.A., Blanchette J.M., and Collins A.C. Sensitivity to the seizure-inducing effects of nicotine is associated with strain-specific variants of the alpha 5 and alpha 7 nicotinic receptor subunit genes. J Pharmacol Exp Ther 284 (1998) 1104-1111
160. Stitzel J.A., Dobelis P., Jimenez M., and Collins A.C. Long sleep and short sleep mice differ in nicotine-stimulated 86Rb+ efflux and alpha4 nicotinic receptor subunit cDNA sequence. Pharmacogenetics 11 (2001) 331-339
161. Sullivan P.F., Eaves L.J., Kendler K.S., and Neale M.C. Genetic case-control association studies in neuropsychiatry. Arch Gen Psychiatry 58 (2001) 1015-1024
162. Sung Y.H., Song J., and Lee H.W. Functional genomics approach using mice. J Biochem Mol Biol 37 (2004) 122-132
163. Suzuki T., Ise Y., Maeda J., and Misawa M. Mecamylamine-precipitated nicotine-withdrawal aversion in Lewis and Fischer 344 inbred rat strains. Eur J Pharmacol 369 (1999) 159-162
164. Swan G.E., Carmelli D., and Cardon L.R. The consumption of tobacco, alcohol, and coffee in Caucasian male twins: a multivariate genetic analysis. J Subst Abuse 8 (1996) 19-31
165. Swan G.E., Hops H., Wilhelmsen K.C., Lessov-Schlaggar C.N., Cheng L.S., Hudmon K.S., et al. A genome-wide screen for nicotine dependence susceptibility loci. Am J Med Genet B Neuropsychiatr Genet 141 (2006) 354-360
166. Sziraki I., Lipovac M.N., Hashim A., Sershen H., Allen D., Cooper T., et al. Differences in nicotine-induced dopamine release and nicotine pharmacokinetics between Lewis and Fischer 344 rats. Neurochem Res 26 (2001) 609-617
167. Tapper A.R., McKinney S.L., Nashmi R., Schwarz J., Deshpande P., Labarca C., et al. Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science 306 (2004) 1029-1032
168. Tapper A.R., McKinney S.L., Marks M.J., and Lester H.A. Nicotine responses in hypersensitive and knockout alpha 4 mice account for tolerance to both hypothermia and locomotor suppression in wild-type mice. Physiol Genomics 31 (2007) 422-428
169. Thewissen R., van den Hout M., Havermans R.C., and Jansen A. Context-dependency of cue-elicited urge to smoke. Addiction 100 (2005) 387-396
170. Thewissen R., Snijders S.J., Havermans R.C., van den Hout M., and Jansen A. Renewal of cue-elicited urge to smoke: implications for cue exposure treatment. Behav Res Ther 44 (2006) 1441-1449
171. Thorgeirsson T.E., Geller F., Sulem P., Rafnar T., Wiste A., Magnusson K.P., et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452 (2008) 638-642
172. Tritto T., Marley R.J., Bastidas D., Stitzel J.A., and Collins A.C. Potential regulation of nicotine and ethanol actions by alpha4-containing nicotinic receptors. Alcohol 24 (2001) 69-78
173. Tritto T., Stitzel J.A., Marks M.J., Romm E., and Collins A.C. Variability in response to nicotine in the LSxSS RI strains: potential role of polymorphisms in alpha4 and alpha6 nicotinic receptor genes. Pharmacogenetics 12 (2002) 197-208
174. Tritto T., McCallum S.E., Waddle S.A., Hutton S.R., Paylor R., Collins A.C., et al. Null mutant analysis of responses to nicotine: deletion of beta2 nicotinic acetylcholine receptor subunit but not alpha7 subunit reduces sensitivity to nicotine-induced locomotor depression and hypothermia. Nicotine Tob Res 6 (2004) 145-158
175. True W.R., Heath A.C., Scherrer J.F., Waterman B., Goldberg J., Lin N., et al. Genetic and environmental contributions to smoking. Addiction 92 (1997) 1277-1287
176. True W.R., Xian H., Scherrer J.F., Madden P.A., Bucholz K.K., Heath A.C., et al. Common genetic vulnerability for nicotine and alcohol dependence in men. Arch Gen Psychiatry 56 (1999) 655-661
177. Vetter D.E., Liberman M.C., Mann J., Barhanin J., Boulter J., Brown M.C., et al. Role of alpha9 nicotinic ACh receptor subunits in the development and function of cochlear efferent innervation. Neuron 23 (1999) 93-103
178. Vink J.M., Beem A.L., Posthuma D., Neale M.C., Willemsen G., Kendler K.S., et al. Linkage analysis of smoking initiation and quantity in Dutch sibling pairs. Pharmacogenomics J 4 (2004) 274-282
179. Vink J.M., Willemsen G., and Boomsma D.I. Heritability of smoking initiation and nicotine dependence. Behav Genet 35 (2005) 397-406
180. Vink J.M., Posthuma D., Neale M.C., Eline Slagboom P., and Boomsma D.I. Genome-wide linkage scan to identify Loci for age at first cigarette in Dutch sibling pairs. Behav Genet 36 (2006) 100-111
181. Walters C.L., Brown S., Changeux J.P., Martin B., and Damaj M.I. The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology (Berl) 184 (2006) 339-344
182. Wang D., Ma J.Z., and Li M.D. Mapping and verification of susceptibility loci for smoking quantity using permutation linkage analysis. Pharmacogenomics J 5 (2005) 166-172
183. Wang N., Orr-Urtreger A., Chapman J., Rabinowitz R., Nachman R., and Korczyn A.D. Autonomic function in mice lacking alpha5 neuronal nicotinic acetylcholine receptor subunit. J Physiol 542 (2002) 347-354
184. Wang W.Y., Barratt B.J., Clayton D.G., and Todd J.A. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 6 (2005) 109-118
185. Watkins-Chow D.E., and Pavan W.J. Genomic copy number and expression variation within the C57BL/6J inbred mouse strain. Genome Res 18 (2008) 60-66
186. Wehner J.M., Keller J.J., Keller A.B., Picciotto M.R., Paylor R., Booker T.K., et al. Role of neuronal nicotinic receptors in the effects of nicotine and ethanol on contextual fear conditioning. Neuroscience 129 (2004) 11-24
187. Wolfer D.P., Crusio W.E., and Lipp H.P. Knockout mice: simple solutions to the problems of genetic background and flanking genes. Trends Neurosci 25 (2002) 336-340
188. Xian H., Scherrer J.F., Madden P.A., Lyons M.J., Tsuang M., True W.R., et al. The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit. Nicotine Tob Res 5 (2003) 245-254
189. Xian H., Scherrer J.F., Madden P.A., Lyons M.J., Tsuang M., True W.R., et al. Latent class typology of nicotine withdrawal: genetic contributions and association with failed smoking cessation and psychiatric disorders. Psychol Med 35 (2005) 409-419
190. Xu W., Orr-Urtreger A., Nigro F., Gelber S., Sutcliffe C.B., Armstrong D., et al. Multiorgan autonomic dysfunction in mice lacking the beta2 and the beta4 subunits of neuronal nicotinic acetylcholine receptors. J Neurosci 19 (1999) 9298-9305
191. Xu W., Gelber S., Orr-Urtreger A., Armstrong D., Lewis R.A., Ou C.N., et al. Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 96 (1999) 5746-5751
192. Zeiger J., Haberstick B.C., Schlaepfer I., Collins A.C., Corley R.P., Crowley T.J., et al. The neuronal nicotinic receptor subunit genes (CHRNA6 and CHRNB3) are associated with subjective responses to tobacco. Hum Mol Genet 17 (2008) 724-734